Stray Dog
EN中文
EN中文

Prices are Hyperliquid perpetual futures: contracts that track each stock and trade 24/7. They are not exchange prices and can differ from them, most of all while US markets are closed. Change is over 24 hours. For information only.

  • TSLA—
  • PLTR—
  • HIMS—
  • SPCX—
  • SOFI—
  • BTC—
…Loading prices
PLTR

UK tail risk escalates: Burnham reportedly wants Palantir replaced in the NHS and MoD…

Sources (3)

UK political backlash against Palantir has moved from noise-level friction (a local police trial with EMSOU was dropped) to a revenue tail risk that can be sized. Reports from July and early October say that new PM Andy Burnham intends to replace Palantir in the NHS and the MoD with domestic in-house alternatives; his office has not commented publicly.

Read more

The core contract at risk is the 2023 NHS England Federated Data Platform (FDP) deal: 7 years, capped at £330 million (about $440 million), with a break clause effective in early 2027, exactly the legal exit window. Palantir has been making its case: Tom Watson, a former Labour deputy leader, is a senior vice president and has been a part-time adviser since 2024, and Palantir warned Parliament before 10 Oct that mob rule should not decide contract awards. The nature of the risk has shifted from reputational to revenue-linked, but it is still reported intent plus an exit clause, not an executed termination. Replacing a platform in-house takes a long time and costs a lot, so execution is uncertain. The same investigation, led by Follow the Money with 18 partners including EL PAÍS and The Nerve, puts a number on Palantir's European footprint: national contracts in 11 countries, and at least €1.4 billion paid by European authorities, converted at today's exchange rates and not tied to a single period. Most of it is British: the UK government is Palantir's biggest European customer, at about £992 million. In 8 of the 11 countries (Spain, the UK, Italy, the Netherlands, Sweden, Finland, Denmark and Ukraine) the clients include the defence ministry or armed forces. The story cuts both ways. It supports the European sovereign and defence moat thesis (a networked position across 8 militaries rather than a single contract), but that same depth is what triggered a coordinated political backlash across countries. The €1.4 billion is a cumulative minimum, not an annual figure, so do not read it as incremental revenue. Watch the 2 Nov Q3 results for any UK or EMEA commercial revenue or RPO commentary.

Key evidence

  • Reports from July and early October say that new UK PM Andy Burnham intends to replace Palantir in the NHS and the MoD with domestic in-house alternatives. His office has not commented publicly
  • Contract at risk: the NHS England Federated Data Platform (FDP), signed in 2023, 7 years, capped at £330 million (about $440 million)
  • The FDP contract has a break clause effective in early 2027, the legal exit window
  • Tom Watson, a former Labour deputy leader, is a Palantir senior vice president and has been a part-time adviser to the company since 2024 (his critics call him a lobbyist)
  • Palantir warned Parliament before 10 Oct that mob rule should not decide contract awards
  • Earlier UK friction was noise-level: the local police trial with EMSOU (East Midlands Special Operations Unit) was not continued
Show 3 more
  • Same investigation, led by Follow the Money with 18 partners including EL PAÍS and The Nerve: Palantir has national-level contracts in 11 European countries
  • At least €1.4 billion paid by European authorities, converted at today's exchange rates and not tied to a single period. Most of it is British: the UK government is Palantir's biggest European customer, at about £992 million
  • In 8 of those countries (Spain, the UK, Italy, the Netherlands, Sweden, Finland, Denmark and Ukraine) the defence ministry or armed forces are clients

Catalysts to watch

  • PLTR Q3 results on 2 Nov 2026: any UK or EMEA commercial revenue or RPO commentary
  • The early 2027 FDP contract break window
  • Any formal UK government procurement notice to replace FDP
  • Other European countries following the UK lead on in-house replacement
  • Any pushback or reversal from the UK Labour party on Burnham's reported position

Risks

  • Reported intent and an exit clause are not an executed termination, and in-house replacement is long, expensive and uncertain in execution
  • The €1.4 billion is a cumulative minimum not tied to a single period, not an annual figure, so do not confuse it with incremental revenue
  • The investigation's framing may overstate the political backlash, and actual procurement decisions are slower and more bureaucratic
  • PLTR has survived similar political heat before (the NHS Covid data store controversy)
  • Watch for market mispricing: a story that cuts both ways could be read as broader moat validation or as a mounting tail risk, and the share price reaction depends on which narrative wins

Sources 3

  1. EL PAÍS investigation, 16 Oct 2026
  2. Follow the Money, lead partner of the investigation
  3. Multiple corroborating outlets, 16 Oct 2026

A brief is a lead for our research, not a verified conclusion or advice.